Evan B. Cunningham

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

Jason Grebely, Olav Dalgård, Brian Conway et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 286 citations · Full text

Hepatology, Hepatitis C, Treatment And Prevention +9

Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs

Jason Grebely, Sarah Larney, Amy Peacock et al. · Addiction · 2018 · 253 citations · Full text

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Alison D. Marshall, Evan B. Cunningham, Stine Nielsen et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 146 citations · Full text

Vaccination, Hcv Infection, Viral Hepatitis +7

Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study

Behzad Hajarizadeh, Jason Grebely, Marianne Byrne et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 95 citations · Full text

Preventive Medicine, Treatment And Prevention, Viral Hepatitis +9

Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005‐2014: The <scp>HITS</scp>‐p study

Evan B. Cunningham, Behzad Hajarizadeh, Neil Arvin Bretaña et al. · Journal of Viral Hepatitis · 2017 · 80 citations · Full text